- Home
- OBAI vs HBIO Comparison
OBAI vs HBIO Comparison
Compare OBAI & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OBAI | HBIO |
|---|---|---|
| Founded | 2017 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.2M | 25.7M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | OBAI | HBIO |
|---|---|---|
| Price | $0.53 | $6.69 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 1.4M | 61.8K |
| Earning Date | 05-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,176,000.00 |
| Revenue This Year | N/A | $4.77 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.44 | $0.28 |
| 52 Week High | $19.95 | $7.00 |
Technical Indicators
Market Signals| Indicator | OBAI | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 21.65 | 64.52 |
| Support Level | $0.44 | $0.47 |
| Resistance Level | $1.66 | $7.00 |
| Average True Range (ATR) | 0.10 | 0.46 |
| MACD | 0.10 | -0.11 |
| Stochastic Oscillator | 18.73 | 79.00 |
Price Performance
Historical ComparisonAbout OBAI TG-17 Inc. Common Stock
Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported more than 1.4 million security service requests, including over 10,000 emergencies and life-saving interventions.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.